Literature DB >> 24258409

The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects.

Motoyuki Otsuka1, Takahiro Kishikawa, Takeshi Yoshikawa, Motoko Ohno, Akemi Takata, Chikako Shibata, Kazuhiko Koike.   

Abstract

MicroRNAs (miRNAs) are small, noncoding RNA molecules that regulate gene expression post-transcriptionally through complementary base pairing with thousands of messenger RNAs. Although the precise biological functions of individual miRNAs are still unknown, miRNAs are speculated to play important roles in diverse biological processes through fine regulation of their target gene expression. A growing body of data indicates the deregulation of miRNAs during hepatocarcinogenesis. In this review, we summarize recent findings regarding deregulated miRNA expression and their possible target genes in hepatocarcinogenesis, with emphasis on inflammation-related hepatocarcinogenesis. Because miRNA-based strategies are being applied to clinical therapeutics, precise knowledge of miRNA functions is crucial both scientifically and clinically. We discuss the current open questions from these points of view, which must be clarified in the near future.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24258409     DOI: 10.1007/s00535-013-0909-8

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  145 in total

Review 1.  Role of microRNAs in plant and animal development.

Authors:  James C Carrington; Victor Ambros
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

2.  MicroRNA genes are transcribed by RNA polymerase II.

Authors:  Yoontae Lee; Minju Kim; Jinju Han; Kyu-Hyun Yeom; Sanghyuk Lee; Sung Hee Baek; V Narry Kim
Journal:  EMBO J       Date:  2004-09-16       Impact factor: 11.598

3.  Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model.

Authors:  Elisa Callegari; Bahaeldin K Elamin; Ferdinando Giannone; Maddalena Milazzo; Giuseppe Altavilla; Francesca Fornari; Luciano Giacomelli; Lucilla D'Abundo; Manuela Ferracin; Cristian Bassi; Barbara Zagatti; Fabio Corrà; Elena Miotto; Laura Lupini; Luigi Bolondi; Laura Gramantieri; Carlo M Croce; Silvia Sabbioni; Massimo Negrini
Journal:  Hepatology       Date:  2012-07-13       Impact factor: 17.425

4.  MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling.

Authors:  J-P Zhang; C Zeng; L Xu; J Gong; J-H Fang; S-M Zhuang
Journal:  Oncogene       Date:  2013-09-09       Impact factor: 9.867

5.  MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.

Authors:  Dong Li; Xingguang Liu; Li Lin; Jin Hou; Nan Li; Chunmei Wang; Pin Wang; Qian Zhang; Peng Zhang; Weiping Zhou; Zhengxin Wang; Guoshan Ding; Shi-Mei Zhuang; Limin Zheng; Wenzhao Tao; Xuetao Cao
Journal:  J Biol Chem       Date:  2011-08-30       Impact factor: 5.157

6.  MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells.

Authors:  Teng Xu; Ying Zhu; Yujuan Xiong; Yi-Yuan Ge; Jing-Ping Yun; Shi-Mei Zhuang
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

7.  Hepatitis B virus X protein upregulates oncogene Rab18 to result in the dysregulation of lipogenesis and proliferation of hepatoma cells.

Authors:  Xiaona You; Fabao Liu; Tao Zhang; Yinghui Li; Lihong Ye; Xiaodong Zhang
Journal:  Carcinogenesis       Date:  2013-03-07       Impact factor: 4.944

8.  The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.

Authors:  Ulf Klein; Marie Lia; Marta Crespo; Rachael Siegel; Qiong Shen; Tongwei Mo; Alberto Ambesi-Impiombato; Andrea Califano; Anna Migliazza; Govind Bhagat; Riccardo Dalla-Favera
Journal:  Cancer Cell       Date:  2010-01-07       Impact factor: 31.743

9.  Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.

Authors:  Laura Gramantieri; Manuela Ferracin; Francesca Fornari; Angelo Veronese; Silvia Sabbioni; Chang-Gong Liu; George A Calin; Catia Giovannini; Eros Ferrazzi; Gian Luca Grazi; Carlo M Croce; Luigi Bolondi; Massimo Negrini
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

Review 10.  Role of miR-122 and lipid metabolism in HCV infection.

Authors:  Takasuke Fukuhara; Yoshiharu Matsuura
Journal:  J Gastroenterol       Date:  2012-09-11       Impact factor: 7.527

View more
  13 in total

Review 1.  Diagnostic and therapeutic application of noncoding RNAs for hepatocellular carcinoma.

Authors:  Chikako Shibata; Motoyuki Otsuka; Takahiro Kishikawa; Motoko Ohno; Takeshi Yoshikawa; Akemi Takata; Kazuhiko Koike
Journal:  World J Hepatol       Date:  2015-01-27

Review 2.  MicroRNAs and liver disease.

Authors:  Motoyuki Otsuka; Takahiro Kishikawa; Takeshi Yoshikawa; Mari Yamagami; Motoko Ohno; Akemi Takata; Chikako Shibata; Rei Ishibashi; Kazuhiko Koike
Journal:  J Hum Genet       Date:  2016-05-26       Impact factor: 3.172

Review 3.  MICA SNPs and the NKG2D system in virus-induced HCC.

Authors:  Kaku Goto; Naoya Kato
Journal:  J Gastroenterol       Date:  2014-10-01       Impact factor: 7.527

4.  Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma.

Authors:  Cuiping Wang; Yang Sun; Huanwen Wu; Shuangni Yu; Li Zhang; Yunxiao Meng; Mingyang Liu; Haiyan Yang; Pingping Liu; Xinxin Mao; Zhaohui Lu; Jie Chen
Journal:  Tumour Biol       Date:  2015-06-30

Review 5.  Regulation of hepatocyte identity and quiescence.

Authors:  Carmen Berasain; Matías A Avila
Journal:  Cell Mol Life Sci       Date:  2015-06-19       Impact factor: 9.261

Review 6.  Latest developments in precancerous lesions of hepatocellular carcinoma.

Authors:  Zhao-Shan Niu; Xiao-Jun Niu; Wen-Hong Wang; Jing Zhao
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

7.  MicroRNA-23a downregulates the expression of interferon regulatory factor-1 in hepatocellular carcinoma cells.

Authors:  Yihe Yan; Zhihai Liang; Qiang Du; Muqing Yang; David A Geller
Journal:  Oncol Rep       Date:  2016-06-09       Impact factor: 3.906

8.  Deregulation of miR-34a and Its Chaperon Hsp70 in Hepatitis C virus-Induced Liver Cirrhosis and Hepatocellular Carcinoma Patients

Authors:  Rasha H Shehata; Soha S Abdelmoneim; Osman A Osman; Ahmad F Hasanain; Amany Osama; Sahar S Abdelmoneim; Eman A Toraih
Journal:  Asian Pac J Cancer Prev       Date:  2017-09-27

9.  MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis.

Authors:  Aline de Conti; Juliana Festa Ortega; Volodymyr Tryndyak; Kostiantyn Dreval; Fernando Salvador Moreno; Ivan Rusyn; Frederick A Beland; Igor P Pogribny
Journal:  Oncotarget       Date:  2017-08-01

Review 10.  Non-coding RNAs, the Trojan horse in two-way communication between tumor and stroma in colorectal and hepatocellular carcinoma.

Authors:  Cristina- Sorina Cătană; Martin Pichler; Gianluigi Giannelli; Robert M Mader; Ioana Berindan-Neagoe
Journal:  Oncotarget       Date:  2017-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.